US8999957, Table 2, Compound 48

ID: ALA3654524

Chembl Id: CHEMBL3654524

PubChem CID: 56591159

Max Phase: Preclinical

Molecular Formula: C30H31FN6O2

Molecular Weight: 526.62

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(F)c1CN1C[C@H](C)C[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccc5nn(C)cc5c4)c3c2)C1

Standard InChI:  InChI=1S/C30H31FN6O2/c1-18-11-22(16-37(14-18)17-24-25(31)5-4-6-28(24)39-3)32-30(38)20-8-10-27-23(13-20)29(34-33-27)19-7-9-26-21(12-19)15-36(2)35-26/h4-10,12-13,15,18,22H,11,14,16-17H2,1-3H3,(H,32,38)(H,33,34)/t18-,22-/m1/s1

Standard InChI Key:  PQSHODILBAUMMD-XMSQKQJNSA-N

Associated Targets(non-human)

Mapk3 Mitogen-activated protein kinase 3 (111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 526.62Molecular Weight (Monoisotopic): 526.2493AlogP: 4.90#Rotatable Bonds: 6
Polar Surface Area: 88.07Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.37CX Basic pKa: 6.87CX LogP: 4.77CX LogD: 4.65
Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.33Np Likeness Score: -1.51

References

1.  (2015)  Heterocyclic compounds as ERK inhibitors, 

Source

Source(1):